Skip to main content
. Author manuscript; available in PMC: 2022 Sep 1.
Published in final edited form as: Liver Transpl. 2021 Jul 21;27(9):1248–1261. doi: 10.1002/lt.26073

Table 2.

Univariate and multivariable logistic regressions to evaluate factors associated with occult disease in all patients. Pseudo R-squared = 0.05 for multivariable regression.

Univariate Multivariable

Independent variables Odds ratio 95% CI P-value Odds ratio 95% CI P-value

Age at transplant 1.00 0.98–1.02 0.99 -- -- --

Female gender 0.77 0.52–1.12 0.18 -- -- --

Etiology of liver disease -- -- --
 Hepatitis C 0.76 0.54–1.06 0.11
 Hepatitis B 0.86 0.48–1.53 0.60
 Alcohol 1.45 0.80–2.64 0.22

Biochemical MELD score at time of transplant 1.05 1.03–1.07 <0.001 1.02 1.00–1.05 0.048

Most recent AFP prior to transplant 1.00 1.00–1.00 0.40 -- -- --

Days on waitlist 1.00 1.00–1.00 0.93 -- -- --

Received pre-transplant treatment
 TACE 0.57 0.42–0.78 <0.001 -- --
 RFA 0.78 0.50–1.21 0.27 --
 Resection 1.26 0.46–3.46 0.65
 Radioembolization 0.39 0.10–1.47 0.16
 Percutaneous ethanol injection 2.57 0.24–27.12 0.43
 Number of treatments 0.79 0.67–0.92 0.003

Most recent pre-transplant imaging
 MRI Ref. -- -- Ref. -- --
 CT 1.98 1.18–3.31 0.01 1.82 1.07–3.11 0.03
 Ultrasound 6.72 1.93–23.31 0.003 4.15 1.11–15.48 0.03

Findings on preoperative imaging
 PVT 2.02 1.22–3.39 0.007 1.97 1.14–3.40 0.02
 TIPS 5.22 2.37–11.49 <0.001 4.16 1.84–9.40 <0.001
 Indeterminate lesion(s) 1.47 0.87–1.48 0.02 1.50 1.02–2.18 0.04

Days from imaging to transplant 1.00 1.00–1.00 0.16 -- -- --

AFP = alpha-fetoprotein. CI = confidence interval. CT = computerized tomography. MELD = Model for End-Stage Liver Disease. MRI = magnetic resonance imaging. PVT = portal venous thrombus. RFA = radiofrequency ablation. TACE = trans-arterial chemoembolization. TIPS = transjugular intrahepatic portosystemic shunt.